Artificial Intelligence | Machine Learning Dyno Therapeutics | Reshaping Gene Therapy with AI-Powered Vectors


Enterprise, Biotechnology, Healthcare, Data Science, Gene Therapy, Genome Editing Cambridge, MA, United States

Dyno Therapeutics

Artificial Intelligence | Machine Learning


Dyno Therapeutics | Reshaping Gene Therapy with AI-Powered Vectors

Dyno Therapeutics

Biotechnology, Healthcare, Data Science, Gene Therapy, Genome Editing


Cambridge, MA, United States

Dyno Therapeutics is pioneering artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies. Our team includes world-class molecular and synthetic biologists, protein engineers, and gene therapy scientists working alongside software engineers, data scientists, and AI and machine learning experts. As we create AI-powered gene therapies that enhance the life-changing potential of gene therapies for millions of patients, we believe the future is within reach.

Gene vectors are the key to enabling gene therapies to reach a wider range of diseases and patients. Success in gene therapy relies on the vector’s ability to safely and precisely deliver a gene payload to the intended target cells and tissues. The efficacy of gene therapies, however, is currently limited by the roster of naturally occurring vectors, which are not optimized for disease treatment.

 

B2B

51 to 100

Seed

$9,000,000

Scaling Up

2018

 
 

Healthcare
Biotechnology

N/A

Reduce Operational Cost

 
 

N/A

Yes

Active

 
 

   Machine Learning


Gene Therapy

Gene Therapy

Health Care Systems

Health Care Systems

Biomedical Insights

Biomedical Insights


N/A

 

   Software


PostgreSQL

PostgreSQL

Sqlachemy

Sqlachemy

SSL

SSL

Python

Python

SQL

SQL

AWS

AWS

Kubeflow

Kubeflow


N/A

 
 

View All

Principal/Sr. Scientist, Program Lead - Gene Therapy; AAV Engineering

Cambridge, Massachusetts

Scientist/Sr. Scientist - Gene Therapy

Cambridge, Massachusetts

Software Engineer

Cambridge, Massachusetts

Sr. Research Associate - Library Cloning; AAV Engineering

Cambridge, Massachusetts

Research Associate - Tissue Analysis; AAV Engineering

Cambridge, Massachusetts

 

AI/ML Professionals

Want to work at Dyno Therapeutics?

We can introduce you to the right person at Dyno Therapeutics

Talk to our Talent Team

 

8

1

$100 M

Company was founded 2018 and it took almost 3 years (May 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

05/06/2021

Series A

$100 M

Andreessen Horowitz, Casdin Capital, GV, Obvious Ventures, Lux Capital, Polaris Partners, CRV, KdT Ventures

Date : 05/06/2021

Round: Series A

$ Raised: $100 M

Investors: Andreessen Horowitz, Casdin Capital, GV, Obvious Ventures, Lux Capital, Polaris Partners, CRV, KdT Ventures

 

Investors

Interested in researching Dyno Therapeutics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Dyno Therapeutics

Request a Demo - Deal Souring Platform

 
Adrian Veres


Adrian Veres
Co-Founder

Eric Kelsic


Eric Kelsic
CEO

Sam Sinai


Sam Sinai
Co-Founder

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Dyno Therapeutics